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Abstract
The crystal structures of unliganded and liganded pMHC molecules provide a structural basis for TCR recognition yet they
represent ‘snapshots’ and offer limited insight into dynamics that may be important for interaction and T cell activation.
MHC molecules HLA-B*3501 and HLA-B*3508 both bind a 13 mer viral peptide (LPEP) yet only HLA-B*3508-LPEP induces a
CTL response characterised by the dominant TCR clonetype SB27. HLA-B*3508-LPEP forms a tight and long-lived complex
with SB27, but the relatively weak interaction between HLA-B*3501-LPEP and SB27 fails to trigger an immune response.
HLA-B*3501 and HLA-B*3508 differ by only one amino acid (L/R156) located on a2-helix, but this does not alter the MHC or
peptide structure nor does this polymorphic residue interact with the peptide or SB27. In the absence of a structural
rationalisation for the differences in TCR engagement we performed a molecular dynamics study of both pMHC complexes
and HLA-B*3508-LPEP in complex with SB27. This reveals that the high flexibility of the peptide in HLA-B*3501 compared to
HLA-B*3508, which was not apparent in the crystal structure alone, may have an under-appreciated role in SB27 recognition.
The TCR pivots atop peptide residues 6–9 and makes transient MHC contacts that extend those observed in the crystal
structure. Thus MD offers an insight into ‘scanning’ mechanism of SB27 that extends the role of the germline encoded
CDR2a and CDR2b loops. Our data are consistent with the vast body of experimental observations for the pMHC-LPEP-SB27
interaction and provide additional insights not accessible using crystallography.
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Introduction
ab T cell receptors (TCR) expressed on the surface of CD8+ T
cells generally recognise specific antigenic or aberrant peptide
fragments (usually 8–10 mers) that are bound to a cell surface
MHC class I molecule. This interaction is central to adaptive T
cell mediated immunity and induces signalling that results in T cell
proliferation and differentiation into effector and memory T cells
[1]. As such, the interaction between a TCR and cognate peptide-
MHC (pMHC) is of great interest and soluble proteins have been
studied extensively predominantly using X-ray crystallography
combined with biophysical studies [2]. These studies have revealed
some general trends. The Va and Vb domains of the TCR each
comprise three complementarity determining regions (CDRs)
which specify the antigen-binding site (Figure 1A). The CDRs
from the Va and Vb chain are positioned over the antigen-binding
cleft of the MHC which is flanked by the a1- and a2-helices
(Figure 1A). Specifically the Va and Vb chains of the TCR sit atop
the amino- (N-) and carboxy (C-) terminal residues of the peptide
respectively (Figure 1B). Generally in this conserved binding
orientation the hypervariable CDR3 loops contact the peptide,
whereas the germline-encoded CDR1 and CDR2 loops contact
the MHC helices [3]. It is likely that evolutionarily conserved
interactions between certain amino acids in the CDR1 and CDR2
loops and the MHC backbone govern the conserved binding
orientation of the TCR atop the MHC, allowing some flexibility in
the binding angle and exact positioning of the TCR [4–8].
Intriguingly TCR-recognition of pMHC can be both degener-
ate and highly specific. For example, the TCR can recognise
structurally different MHC-bound peptides yet also discriminate
between peptides and MHCs that differ by a change as slight as a
single polymorphism. This anomaly may be influenced by several
factors including the extent of initial interactions made between
the TCR-pMHC, modest changes at the TCR-pMHC interface
that facilitate improved binding and stabilisation of the TCR-
pMHC interaction [9] and the half-life of a productive interaction
[10]. TCR-pMHC interactions typically have a slow association
rate of binding (typically 10
3–10
5 M
21.s
21) [11], whereas the
dissociation rate (0.1–100 s
21) is typically rapid and these kinetics
are characteristic of a low affinity interaction [11]. There is
substantial evidence that the in vitro and in vivo binding kinetics and
efficiency of the TCR-pMHC interaction is correlated with the
nature of the T cell response [12]. This suggests the TCR must
engage the pMHC long enough to transmit a biological signal
PLoS Computational Biology | www.ploscompbiol.org 1 March 2012 | Volume 8 | Issue 3 | e1002404across the T cell membrane [13–16] and further studies have
shown that successive TCR engagement leads to cumulative
signalling and T cell activation [12]. Despite the existence of
general rules of TCR-pMHC engagement, two pertinent questions
remain unanswered; what guides MHC restriction, and how does
TCR-pMHC binding lead to T cell activation?
While X-ray crystallography is a powerful technique for
visualising molecular structures such as pMHC and TCR, the
structure determined represents a space and time average of all
molecules in the crystal lattice. Therefore information about the
flexibility of the molecule is limited and can only be gained from
the atomic temperature (B) factors of crystallographic models,
however these values must be treated cautiously. As flexibility and
dynamics of TCR-pMHC interactions may play an important role
in governing their biological function, X-ray crystallography offers
limited insight into these processes. However this information can
be obtained computationally using the X-ray crystal structure
combined with molecular dynamics (MD) simulations. The
simulations offer the ability to calculate the time dependent
behaviour of a molecular system over time, extending the
information gained from crystallographic data and in this instance
offering insights into the role of dynamics in a particular TCR-
pMHC system.
Previous research has shown that an unusually long 13 mer
peptide from the BZLF1 antigen of Epstein-Barr virus (amino
acids 52–64, sequence LPEPLPQGQLTAY abbr LPEP) could
bind HLA-B*3501 and HLA-B*3508 [17], but only HLA-B*3508-
LPEP generates a robust and biased CTL response. Studies using
T cells of a dominant clonetype (SB27) and the recombinant SB27
TCR indicated that SB27 could discriminate between HLA-
B*3501-LPEP and HLA-B*3508-LPEP and yet they differ by only
by a single polymorphism located on the a2-helix of the MHC
(HLA-B*3508
R156; HLA-B*3501
L156). A structural comparison of
the pMHCs revealed localised conformational changes accommo-
dating the polymorphic residue, causing a 1 A ˚ rigid body shift in
the a2-helix from residues 145–158 originating from Val
152. This
shift caused the broadening of the HLA-B*3508-LPEP antigen
binding cleft and was postulated to favour the interaction of the
SB27 TCR [18]. Further, the SB27-B*3508-LPEP structure
revealed that the polymorphic residue (Arg156) did not contact
the TCR and hence could not directly influence T cell selection.
The structure of the SB27-HLA-B*3508-LPEP also revealed an
orthogonal docking mode of TCR-pMHC binding that uncon-
ventionally was dominated by peptide-mediated contacts with
SB27 due to the length and bulged nature of the peptide. The
limited MHC-mediated contacts that were made were described
as the minimal residues required to produce a productive
interaction and included residues Gln65 and Thr69 on the a1-
helix and Gln155 on the a2-helix (referred to as the ‘restriction
triad’) [19]. Further, comparison of the different complexes within
the crystal asymmetric unit suggested a ‘rocking’ motion for the
TCR in the two complex crystal forms (Figure 1C). While these
studies provided valuable insights into the discriminatory ability of
SB27, the dynamics of HLA-B*3508-LPEP and HLA-B*3501-
LPEP and relevance to T cell selection have not been explored. To
further comprehend the differential recognition of SB27 for HLA-
B*3501-LPEP and HLA-B*3508-LPEP we performed MD
simulations of both unliganded pMHCs and also HLA-B*3508-
LPEP in complex with SB27. These studies reveal differences in
the epitope dynamics between the unliganded pMHC structures
that may govern the subsequent encounter with SB27. In addition
we observe intriguing dynamics at the TCR-pMHC interface that
may be indicative of the proposed mechanism of TCR scanning.
Taken together, these results may provide significant insight into
the molecular principles governing the role of epitope flexibility in
SB27 recognition and set the precedent for similar studies of other
TCR-pMHC systems.
Results/Discussion
MD reveals greater flexibility of the peptide compared to
the MHC
The conformation of the bound LPEP peptide is almost
identical in the crystal structures of HLA-B*3501 and HLA-
B*3508 (RMSD=0.24 A ˚ over 13 Ca atoms). We assessed the
conformational flexibility of the unusually long LPEP peptide
bound to MHC in both HLA-B*3501 and HLA-B*3508 using
molecular dynamics (Figure 2 and Video S1). In both cases the
amino acids at the termini of the peptide were immobile,
consistent with their role in anchoring the peptide into the A-
and F- pockets of the MHC respectively [20–22]. Whilst the
termini of the peptides were consistently anchored, the peptide in
both alleles was considerably more mobile than the MHC helices
(Figure 2A). However, the simulations showed a marked difference
in the conformational flexibility of the bound peptide depending
on the MHC allele to which it was bound. When bound to HLA-
B*3508 the peptide exhibited moderate flexibility (RMSF ,1.5 A ˚;
Figure 2A, B), which is also similar to the conformation seen when
HLA-B*3508-LPEP is bound to the SB27 TCR. However when
the peptide was bound to HLA-B*3501 the peptide mobility
increased two-fold, particularly at the peak of the bulge from
residues from 5 to 11 (Figure 2A, C; Video S1). The difference in
flexibility of the HLA-B*3501 versus HLA-B*3508-bound peptide
is moderately consistent with differences in the average temper-
ature factors of the peptide in the respective crystal structures
(23.1 A ˚ 2 and 15.8 A ˚ 2 respectively [18]). These observations are
also consistent with the finding that HLA-B*3501-LPEP is 4uC less
thermostable than HLA-B*3508-LPEP [18].
Given the high structural similarity between the two allelic
MHC variants, we speculate that the difference in peptide
flexibility when bound to the two alleles may be attributed to
the polymorphic residue at position 156. In HLA-B*3508 the
Author Summary
When pathogens replicate within a host cell, their proteins
are degraded into peptides, which are captured by the
major histocompatibility complex (MHC) and brought to
the cell surface. The peptide-MHC (pMHC) is surveyed by T
cell receptors (TCRs) expressed on the surface of T cells. If
the peptide is foreign, the peptide-MHC-TCR interaction
initiates an immune response to eliminate the pathogen.
However, the combinations of pMHC and TCRs are diverse.
We ask how TCRs discriminate between structurally similar
pMHCs? We address this by focusing on two MHC
molecules that differ by a single change, both bind the
same peptide but only one instigates a dominant immune
response. Intriguingly, the single difference between the
two MHCs does not alter the peptide shape nor does it
contact the peptide or TCR. We examined the flexibility of
the pMHC-TCR interface using molecular dynamics simu-
lations. We observed differences in the peptide and TCR
flexibilities that could explain their contrasting physiolo-
gies, as well as clues to how the TCR moves atop the MHC
in order to ‘scan’ it. Our analysis provides insight into a
particular pMHC-TCR interaction not accessible using
crystallographic methods, and indicate dynamics may play
an influential and perhaps under-appreciated role in other
pMHC-TCR systems.
Flexibility at the pMHC-TCR Interface
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LPEP peptide, including Glu3 O-e1 and Thr11 O [18]. In HLA-
B*3508 these bonds may tether the peptide in place, but in HLA-
B*3501 the shorter leucine side chain at position 156 causes the
loss of these bonds and the formation of a cavity [18]. This
increase in space available may permit the LPEP peptide to adopt
alternative conformations not seen in the crystal structure. Indeed,
our simulations show that when bound to HLA-B*3501 the LPEP
Figure 1. Overall cartoon of TCR-pMHC complex SB27-HLA-B*3508-LPEP (PDB ID 2AK4). (A) HLA-B*3508 shown in grey with polymorphic
residue (R156) in green, LPEP peptide shown in red, SB27 TCR shown in yellow and cyan for a- and b- chains respectively; (B) Superposition of the two
distinct TCR-pMHC complexes within the crystal structure, SB27 a- and b-chains of complex A coloured orange and dark blue respectively and
complex B coloured as per (A); (C) aerial view of antigen binding cleft of HLA-B*3508-LPEP with colours as per (A) and the SB27 TCR removed with the
exception of the CDR loops.
doi:10.1371/journal.pcbi.1002404.g001
Figure 2. MHC and peptide conformational flexibility in MD simulations. (A) RMSFs as calculated from MD simulations for MHC and peptide
residues (inset). Only positions 1 to 180 of the MHC molecules are displayed with the MHC helices underlined. HLA-B*3508 simulations 1 and 2 are in
red and orange respectively and HLA-B*3501 simulations 1 and 2 are in dark and light blue respectively. The boxed inset highlights the RMSFs of the
peptide at positions 1 to 13; (B) Cartoon representation of the crystal structure of HLA-B*3508-LPEP (PDB ID 1ZHL) with helices coloured grey, peptide
in yellow and polymorphic residue in green. MD snapshots of the peptide taken every 10 ns and colour coded in red for simulation 1 and orange for
simulation 2; (C) Cartoon representation of the crystal structure of HLA-B*3501-LPEP (PDB ID 1ZHK) with helices shown in grey, peptide in yellow and
polymorphic residue in green. MD snapshots taken each 10 ns are colour coded dark blue for simulation 1 and light blue for simulation 2.
doi:10.1371/journal.pcbi.1002404.g002
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in the crystal structure (Figure 2C, yellow) and conformations that
approach the hinge region of the a2-helix (residues 150–152;
Figure 2C). Peptide flexibility can be experimentally tested using
biophysical techniques, for example site directed fluorescence
labelling [23,24] and IR spectroscopy [25–27].
Epitope flexibility in HLA-B*3501-LPEP frustrates or
obstructs TCR recognition
Since the conformational variability corresponds to the central
bulged region of the peptide and most of these residues (residues
4–9) are directly involved in TCR binding [19], the simulations
results imply that peptide flexibility may influence T cell selection.
Importantly this possibility could not be appreciated from the
crystal structure alone (Figure 2B). Peptide flexibility may frustrate
the ability of SB27 to form critical contacts with LPEP residues 4–
9. Alternatively or additionally, peptide flux towards the hinge
region of the a2-helix (residues 150–152) may sterically obstruct
the CDR3b loop of SB27 from contacting the MHC. (Figure 1B).
In the SB27-LPEP-HLA*B*3508 complex, the CDR3b loop forms
Van der Waals interactions with residues near the hinge-region of
the a2-helix, including Ala150, Arg151, Glu154, Gln155, and a
salt-bridge with Arg151 [19]. Of note, three of these four CDR3b
residues (151, 154 and 155) are frequently used by TCRs to
contact the MHC [5]. Further, due to the bulged nature of the
LPEP peptide these MHC residues account for a substantial four
out of six that are contacted by SB27 [19]. Therefore it is likely
that the obstruction of these interactions would have a significant
effect on TCR binding. Accordingly the affinity of SB27 for HLA-
B*3501-LPEP is .3-fold weaker than for HLA-B*3508-LPEP and
dissociates approximately 2-fold faster [18], indicating critical
interactions are indeed lost.
Whilst TCRs are able to recognise inherently flexible epitopes
[28,29] it is possible that the flexibility of the LPEP bound to the
HLA-B*3501 may play an under-appreciated role in SB27
binding. Based on the inability of SB27 to adapt to a more highly
flexible but otherwise identical epitope we predict the CDR loops
of SB27, whilst sufficient to adapt to a wide range of epitope
structures, are ‘‘conformationally frustrated’’ or sterically obstruct-
ed by a highly flexible moving peptide target. Our data shows this
discrimination may be due to residues at the periphery of the
SB27-HLA-B*3508-LPEP interface. It is possible that conforma-
tional plasticity of SB27 is fine-tuned to allow discrimination
between such conformationally diverse but otherwise identical
epitopes, contributing to the exquisite specificity of SB27 in LPEP
antigen recognition. Indeed, it has been suggested that antibodies,
which have limited sequence diversity, use conformational
diversity to achieve functional promiscuity [30].
MD reveals insight into possible scanning motion of TCR
on pMHC
Interestingly, and as previously published, four SB27-HLA-
B*3508-LPEP complexes were present in the asymmetric unit
[29]. While the individual components were almost identical, two
subtly different TCR-pMHC conformations were revealed
(Figure 1C), as also observed in the JM22-HLA-A*0201-flu crystal
forms [31]. The difference was attributed to a 12u rotation in the
angle of approach by the TCR consistent with the formation of
new bonds at the interface, and the destruction of others. As
crystal contacts were deemed an unlikely cause of this phenom-
enon, it was postulated that the tilted orientation of the TCR on
the pMHC may offer a glimpse into the scanning mechanism of
the TCR [19]. Using both TCR-pMHC complex conformations
as starting points for MD simulations we show that both complex
conformations exhibit a rocking trajectory that extends beyond the
two positions observed in the crystal structure (Figure 3). However,
the simulations revealed that the rocking trajectory of the TCR in
the two complexes was inconsistent. In complex A the TCR
motion is predominantly parallel to the antigen-binding cleft
(Figure 3A and Video S2) whereas in complex B the TCR
movement is predominantly orthogonal to the antigen-binding
cleft (Figure 3B). There is evidence that the crystalline environ-
ment can select muliple distinct biologically relevant conforma-
tions from an ensemble observed in solution [32–37], and that
cryogenic temperatures of data collection can further bias the
observed conformers [38]. Our simulation results are consistent
with this view. This pronounced rocking motion may be due to the
bulged and protruding nature of the LPEP peptide which has been
shown to limit MHC-TCR interactions [19]. Nonetheless, this
phenomenom may also provide a valuable insight into the
physiological importance and stochastic nature of SB27 TCR
scanning. TCRs may scan the pMHC surface to rapidly
differentiate between the numerous combinations encountered
[39]. It may also provide a mechanism for the TCR to disengage
from the pMHC.
The TCR pivots atop residues 6–9 of the LPEP peptide
Given the protruding nature of the LPEP peptide, the SB27
TCR contacted minimal HLA-B*3508 residues as observed in the
crystal structure [19]. These minimal residues, termed the
‘restriction triad’ (Gln65, Thr69, Gln155) [19] are repeatedly
contacted by TCRs in complex with peptide-MHC class I. Our
MD data supports the observation that contacts with the
restriction triad are made, but indicates that these contacts
fluctuate and may only be transient (Table 1 and Video S3). The
transient nature of these interactions is supported by mutational
studies indicating these residues are non-essential to SB27 CTL
killing [40] and SB27 binding affinity [40]. Furthermore, the
crystal structure of SB27 in complex with LPEP-HLA-B*3508
harbouring the triple alanine mutation of the restriction triad
shows that SB27 forms compensatory interactions and exhibits an
altered docking mode indicative of an adaptable TCR [40]. MD
reveals that the SB27 TCR makes relatively long-lived contacts
with Pro6, Gln7, Gly8 and Gln9 of the bulged LPEP peptide
(Video S3), suggesting the bulged region of the peptide is crucial to
the interaction and also a pivot point of the TCR. The importance
of Pro6, Gln7 and Gly8 is reflected by a glycine substitution
analysis whereby individual substitution to glycine results in
significantly reduced CTL recognition [18]. Also, whilst the triple
alanine substitution of LPEP-HLA-B*3508 causes compensatory
MHC interactions that shifts SB27 docking, the contacts with
Pro6, Gln7, Gly8 and Gln9 of the LPEP peptide predominate and
constitute 32 of the 38 interactions made with the TCR [40].
Therefore taken together the biological data, structural data and
molecular dynamics cumulatively reveal that the SB27 TCR is
indifferent to alterations in the restriction triad residues of the
MHC but highly sensitive to changes in Pro6, Gln7 and Gly8 of
the peptide given the long-lived nature of these interactions. The
peptide-centric nature of the SB27 interaction may be due at least
in part to the unusually long and prominent LPEP-peptide.
TCR binding restricts flexibility of peptide pivot residues
but not MHC
As an intuitive control and to validate our molecular dynamics
simulations we compared the flexibility of the LPEP peptide when
bound to HLA-B*3508 alone (Figure 2A, B) and in complex with
SB27 (Figure 4A, B). In the absence of SB27 we observe flexibility
Flexibility at the pMHC-TCR Interface
PLoS Computational Biology | www.ploscompbiol.org 5 March 2012 | Volume 8 | Issue 3 | e1002404Figure 3. TCR-pMHC scanning. The crystal structure of (A) complex A and (B) complex B is in grey for reference and the maximum movement of
the TCR during the respective simulations is superposed in light blue or dark blue. Orthogonal orientations are shown in the right hand panels. The
arrow highlights the direction of TCR movement during the respective simulations.
doi:10.1371/journal.pcbi.1002404.g003
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upon complexation the flexibility of the pivot residues (6–9) is
reduced (RMSF ,1.0 A ˚; Figure 4A, B) due to their long-lived
hydrogen bonds with TCR. In contrast, TCR binding does not
significantly alter the flexibility of MHC contact residues (Figure 4),
again highlighting the significance of the prominantly bulged
peptide pivot for the TCR interaction.
A dynamic pMHC-TCR footprint
A detailed inspection of the pMHC-TCR interface during the
simulation of SB27-HLA-B*3508-LPEP reveals both short- and
long-lived interactions that occur during the scanning motion
described above (Table 1, Figure 5 and Video S3). We were thus
able to construct a TCR-pMHC footprint that encompasses the
known footprint from crystallographic studies but also encom-
passes additional interactions that may play a role during or even
dictate the lifetime of the interaction. While the simulations
revealed the TCR in each complex adopts a dissimilar rocking
trajectory, both maintained a conserved footprint of contact
residues on the pMHC (Table 1, Figure 5 and Video S3). This
indicates that the TCR contacts the same residues on the pMHC,
but does so randomly rather than adopting a defined pathway.
However in addition to the interactions seen in the crystal
structure that also persist in the simulation, several new and
persistent hydrogen-bonds were identified that are not present in
the crystal structure. Therefore, over the course of the simulation
the SB27 samples additional, remote regions of the a1- and a2-
helix of HLA-B*3508-LPEP (Figure 5A, blue regions). In
particular, in the crystal structure the side chain of Arg62 (a1-
helix) does not interact with either LPEP or SB27, but early in the
simulation undergoes a significant conformational change to form
a salt bridge with Asp56 (SB27 CDR2a; Table 1 and Video S3). It
is interesting to note that these additional MHC contacts are made
by residues in the germline-encoded CDR2a and CDR2b loops
(Table 1, Figure 5B, and Video S3). MD simulations on other
TCR-pMHC systems may reveal that these loops play an even
greater role in MHC-restriction than previously anticipated. In
this instance however, the interactions may represent additional
hot-spots that dictate the SB27-LPEP-B*3508 dynamics, half-life
and therefore T cell signalling. The role of these residues could be
tested experimentally using site directed mutagenesis coupled with
surface plasmon resonance.
Dynamic versus static views of TCR-pMHC interactions
The effect of crystal packing on protein structure has been
studied widely by comparing identical molecules crystallized in
different lattices [32–36]. Indeed in the case of T4 lysozyme,
radically different domain conformations of four molecules in the
crystal lattice have been reported [32], suggesting that crystal
contacts can select distinct conformations from an ensemble and
may provide hints to conformational dynamics. Similarly, two
different conformations were observed in the crystal structure of
the TCR-pMHC complexes that formed the basis of our study.
Our MD results extend the range of these motions, suggesting that
in this case the crystal lattice may have selected compatible
conformations from a diverse ensemble. Furthermore, cryo-
cooling can result in smaller, over-packed models [38], with
significantly reduced or even eliminated motions important for
protein function. This highlights the need for complementary
methods, such as MD that provide important insights into the role
of conformational heterogeneity in TCR-pMHC interactions and
signalling outcome. This will require characterisation of all
molecular species and assemblies at the synapse in the context of
APC T-cell interaction. However, the structural characterisation
of relevant molecular assembles (e.g., including co-receptors CD8/
CD4, the CD3 complexes, and other co-stimulatory factors) is
likely to provide only a static snapshot of a pre-signalling situation,
and our data suggests that a complete understanding of the
signalling events will require a full characterisation of the dynamics
of the process.
In summary, our results reveal a striking contrast between the
dynamic behaviours of the LPEP peptide captured by HLA-
B*3508 compared to HLA-B*3501. The LPEP peptide was found
to be more flexible when bound to HLA-B*3501 versus HLA-
B*3508 and this was attributed to a single polymorphism within
the peptide-binding cleft of the MHC. Notably the inherently
flexible nature of the LPEP peptide in both HLA-B*3501 and
Table 1. Hydrogen bonds between the pMHC and the TCR
observed over the course of the simulations.
MHC TCR
In crystal
structure?
Persistence
Complex A
(% of
simulation)
Persistence
Complex B
(% of
simulation)
a1-helix
Arg62
Ng1/2 CDR2b Asp56
Od1/2 No 54 -
Gln65
Ne2 CDR2b Ser51
Oc No - 10
Gln65
Ne2 CDR2b Glu52
Oe1/2 No - 27
Gln65
Oe1 CDR3a Asn97
Nd2 Yes 23 5
Gln65
Oe1 CDR2b Glu52
N No 7 -
Lys68
Nf CDR2b Glu52
Oe1/2 No 48 39
a2-helix
Arg151
Ng1/2 CDR2a Asp53
Od1/2 No 46 -
Arg151
Ng1/2 CDR2a Glu57
Oe1/2 No - 36
Glu154
Oe1 CDR2a Arg48
Ng2 No - 7
Glu154
Oe1 CDR2a Asn50
Nd2 No 15 9
Glu154
Oe2 CDR2a Asn50
Nd2 Yes 14 6
Gln155
Ne2 CDR3a Phe95
O Yes 3 1
Gln155
O CDR3a Tyr96
Og No - 15
Arg157
Ng1/2 CDR2a Glu54
Oe1/2 No - 27
Peptide
Leu5
O CDR3a Asn97
N Yes 60 52
Pro6
O CDR1b Asn30
Nd2 Yes 42 18
Gln7
Ne2 CDR3a Tyr96
O No 63 46
Gln7
Ne2 CDR3a Ser93
Oc Yes 17 25
Gln7
O CDR1b Asn30
N Yes 4 -
Gln7
O CDR1b Ser31
N Yes 15 61
Gln7
Oe1 CDR1a Tyr31
Og Yes 66 39
Gln7
O1 CDR3a Ser93
Oc Yes 21 25
Gln7
Oe1 CDR1b Tyr33
Og Yes - 5
Gly8
O CDR1b Asn30
N Yes 77 35
Gly8
O CDR1b Asn30
Nd2 Yes 13 18
Gln9
N CDR1b His29
Nd1 Yes 1 1
Gln9
Ne2 CDR1b Asn28
O No 7 15
Gln9
Ne2 CDR1b Asn28
Od1 Yes - -
Gln9
Ne2 CDR1b His29
Nd1 No 35 16
Gln9
Oe1 CDR3b Tyr103
Og No - 5
(-) indicates no interaction observed in simulation.
doi:10.1371/journal.pcbi.1002404.t001
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alone but the marked difference in LPEP flexibility in the two
allotypes may influence subsequent interaction with the SB27
TCR. On the basis of these results we predict that the flexibility of
the SB27 TCR, although sufficient to adapt to a wide range of
HLA-B*3508-LPEP conformations, is unable to engage produc-
tively with a highly flexible peptide, thus causing ‘‘conformational
frustration’’ and a non-productive LPEP-HLA-B*3501 interac-
tion. This may indicate that peptide dynamics plays an influential
role in SB27 T cell selection and activation. Interestingly,
unexpected conformational plasticity in the TCR, which may
play a role in binding different pMHC has been recently reported
[41]. Further, the pivoting motion of SB27 atop HLA-B*3508-
LPEP provides insights into possible scanning mechanisms that
SB27 may use to distinguish between combinations of pMHC
landscapes. To our knowledge this is the first description of TCR
scanning of a cognate pMHC surface using a molecular dynamics
approach. Taken together, these simulations provide several
Figure 4. The flexibility of the LPEP peptide within HLA-B*3508 while complexed to the SB27 TCR. (A) RMSFs as calculated from MD
simulations for MHC and peptide residues. Only positions 1 to 180 of the MHC molecules are displayed with the MHC helices underlined. HLA-B*3508-
LPEP simulations 1 and 2 are in red and orange respectively and HLA-B*3508-LPEP SB27 TCR simulations 1 and 2 are in dark purple and pink
respectively. The boxed insert highlights the RMSFs of the peptide at positions 1 to 13; (B) Cartoon representation of the crystal structure of HLA-
B*3508-LPEP SB27 TCR complex (PDB ID 2AK4) with helices coloured grey, peptide in yellow and polymorphic residue in green. For clarity the SB27
TCR has been removed. MD snapshots of the peptide taken every 10 ns are colour coded as per A.
doi:10.1371/journal.pcbi.1002404.g004
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PLoS Computational Biology | www.ploscompbiol.org 8 March 2012 | Volume 8 | Issue 3 | e1002404Figure 5. The SB27 TCR footprint on HLA-B*3508-LPEP following MD simulation. (A) A comparison of contacts observed in both the crystal
structure and dynamics. MHC or peptide contacts observed in both the crystal structure and dynamics coloured red and orange respectively.
Residues coloured in light or dark blue represent novel short-lived (,50%) or long-lived (.50%) interactions respectively that were observed only
during the simulation. The footprint represents both complex A and complex B as all contacts were conserved between the two simulations with the
exception of Arg157 which was a short-lived contact only observed in the simulation of complex A and Arg151 and Arg162 which were long-lived
contacts only observed in the simulation of complex A; (B) The HLA-B*3508 and LPEP residues contacted by the TCR are coloured according to the
CDR loop from which they are derived. The uncontacted regions of LPEP are in red, residues contacted by CDR2a in yellow, CDR3a in cyan, CDR1b in
green and CDR2b in purple.
doi:10.1371/journal.pcbi.1002404.g005
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crystallography. This study sets the precedent for molecular
dynamics simulations of other TCR-pMHC systems. Given the
unconventional length of the LPEP peptide, it will be interesting to
note whether our observations are particular for the SB27-LPEP-
HLA-B*3508/B*3501 system or are reflective of other, perhaps
more conventional TCR-pMHC systems. Four related studies,
incorporating MD and biophysical techniques have shown that
peptide flexibility, not apparent in the crystalline environment is
also observed with shorter more conventional length peptides [23–
27,42]. This may indicate that peptide flexibility may also be a
feature of shorter peptides, and may play an important role in T-
cell recognition.
Methods
The simulations were based on the published crystal structures
of HLA-B*3501 and HLA-B*3508 each with bound LPEP peptide
(LPEPLPQGQLTAY) (PDB IDs 1ZHK and 1ZHL respectively)
[18], and on the crystal structure of the complex of HLA-B*3508
with the TCR SB27 (PDB ID 2AK4) [19].
The HLA-B*3508-LPEP-TCR complex contains 4 complexes
in the asymmetric unit, with 2 unique conformations designated
Complex A and Complex B, where Complex A comprises chains
K-P and Complex B chains A-E. Missing residues were added to
the structure using Modeller, version 9v6 [43]. The two distinct
crystal structure conformations of the pMHC-TCR complex were
both used as distinct starting points for the molecular dynamics
study of the complex. For the simulations of pMHC-LPEP
complexes the single molecule in the asymmetric unit of the crystal
was used for HLA-B*3501 (PDB ID 1ZHK) and for HLA-B*3508
(PDB ID 1ZHL).
MD simulations were performed using the NAMD 2.7 MD
software package [44] and the CHARMM22 protein force field
[45]. The structures were solvated with waters (TIP3P model) and
0.2 mM NaCl, then subjected to energy minimization. For all
simulations a timestep of 2 fs was used as well as periodic
boundary conditions and PME for electrostatics. The systems were
heated to 300 K with the protein harmonically constrained for
0.4 ns followed by constraining Ca atoms only for 0.8 ns. The
systems were equilibrated for another 1 ns without constraints
before the production runs used for analysis. Parameters for all
simulations were: temperature 300 K, switching distance 10 A ˚,
switching cutoff 12 A ˚, pairlist distance 13.5 A ˚, Langevin damping
coefficient 5 ps
21, Langevin pressure control with a target pressure
of 1.01325 bar.
The systems subjected to MD simulations are as follows:
HLA-B*3501-LPEP: Cubic box with initial dimensions
79.2695.7674.0 A ˚ and PME grid dimensions 80696674 A ˚.
The system contained 51887 atoms, consisting of 15211 waters,
57 ions (34 Na
+ and 23 Cl
2) and 6197 protein atoms, resulting in a
chargeless system. The system was used as the starting point for
two independent simulations of 100 ns each.
HLA-B*3508-LPEP: Cubic box with initial dimensions
79.2695.6674.3 and PME grid dimensions 80696676. The
system contained 52016 atoms, consisting of 15252 waters, 58 ions
(34 Na
+ and 23 Cl
2) and 6202 protein atoms, resulting in a
chargeless system. The system was used as the starting point for
two independent simulations of 100 ns each.
SB27-HLA-B*3508-LPEP (Complex A and Complex B): Cubic box
with initial dimensions of 96 A ˚686 A ˚6162 A ˚ and PME grid
dimensions 966906162. The whole system contained 137926
atoms, consisting of 41502 water molecules, 156 ions (90 Na
+ and
66 Cl
2), 13264 protein atoms in 844 protein residues resulting in a
chargeless system (Complex A). Cubic box with initial dimensions
of 96 A ˚686 A ˚6162 A ˚ and PME grid dimensions 1006906162.
The whole system contained 137872 atoms, consisting of 41484
water molecules, 156 ions (90 Na
+ and 66 Cl
2), 13264 protein
atoms in 844 protein residues (Complex B). Simulations for both
complexes A and B were performed for 100 ns each.
All analyses and visualisations were performed using VMD [46],
PyMOL [47], and custom scripts. Hydrogen bonds were
considered formed for a donor/acceptor cut-off distance of
3.5 A ˚ and an angle with the central hydrogen of 180630u.
RMSF profiles presented in figure 2A and 4A employed Ca
positions of MHC residues 1 to 180 and residues 1 to 13 of the
peptide, with respect to the average structure.
Supporting Information
Video S1 Conformational flexibility of peptide in HLA-B*3501-
LPEP and HLA-B*3508-LPEP during MD simulations. The
polymorphic (R/L156) residue is shown in green. Static snapshots
of the respective simulations are shown in the insets as per
Figure 2B, C.
(MP4)
Video S2 Orthogonal views of MD simulation of HLA-B*3508-
LPEP SB27 TCR complex B. The MHC, LPEP epitope and TCR
are shown in grey, green and yellow/cyan respectively.
(MP4)
Video S3 Detailed view of contacts made at the interface during
the MD simulation of HLA-B*3508-LPEP SB27 TCR complex B.
On the left, cartoon showing hydrogen bonds and salt bridges
(black dotted lines) at the interface between MHC (grey), peptide
(green) and TCR (cyan and yellow); On the right, MHC surface
showing the dynamic TCR footprint. The MHC residues being
contacted by the TCR are coloured red. The inset shows the
corresponding footprint calculated from the crystal structure.
(MP4)
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